Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PlexusDx vs Risen Labs

PlexusDx
Graded #161

Higher grade

vs+10.5
Risen Labs
Graded #403

Lower grade

The verdict

PlexusDx takes it — 67.7/100 to 57.2/100.

PlexusDx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PlexusDx (plexusdx.com) is a US GLP-1 telehealth platform offering compounded weight-loss medications with licensed providers in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePlexusDx +29
74
45
Dose & formulationPlexusDx +24
64
40
Clinical oversightRisen Labs +5
74
79
Labs & monitoringRisen Labs +12
52
64
FulfillmentPlexusDx +10
78
68
Contract termsEven
55
55
PlexusDx · left barRisen Labs · right bar

The numbers

MetricPlexusDxRisen Labs
WeighScore67.7/10057.2/100
GradeCC
Scorecard rank#161#403
Semaglutide$149/mo (starting dose, compounded)Not disclosed
Tirzepatide$249/mo (starting dose, compounded)Not disclosed
CoverageAll 50 states2 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
PlexusDx

Graded #161 · C

Strengths

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Where it loses points

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted
Risen Labs

Graded #403 · C

Strengths

  • Names its compounding pharmacy (Olympia Pharmacy, a 503A compounding pharmacy) and legal entity (Risen Labs LLC)
  • Offers compounded semaglutide and tirzepatide as clinician-guided once-weekly injections
  • Focused clinical intake covering weight loss, men's health, and hormone protocols

Where it loses points

  • GLP-1 pricing is not published; it appears only after you complete the clinical intake
  • Available only to patients in New York and Colorado
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • No LegitScript certification is displayed on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard